Expirel
Track Expiry Dates & Build Better Habits — All in Platform
MediMan
Helthcare Anytime. Anywhere.
@tisankan
Follow on
Categories
Target Audience
Platforms
About MediMan
MediMan is a global telehealth platform for finding doctors, booking appointments, and completing consultations online. Patients can search by specialty, view availability, and consult through video, voice, or chat based on provider settings. After the visit, doctors can issue digital prescriptions and share care notes, so patients keep everything organized in one place.
MediMan also supports lab bookings and report access, enabling patients to upload results and track follow ups across multiple visits. Integrated in app payments and automated reminders help reduce no shows and make the entire flow smoother for both patients and providers.
Designed to scale across regions, MediMan helps patients access trusted medical care faster, reduces waiting time, and improves continuity of care with a simple, secure experience.
Product Insights
MediMan is a web-based healthcare platform that synchronizes appointment scheduling, remote consultations, and medical record management into a single interface. It enables end-to-end patient care through integrated video, voice, and chat communication tools combined with automated payment processing.
- Supports multiple consultation modes including video, voice, and text chat.
- Integrated lab booking system with digital report access and result tracking.
- Automated reminder system and in-app payments to streamline provider workflows.
- Centralized digital prescription and care note storage for patients.
Ideal for: Non-technical users and medical consultants who need a unified web platform to manage global telehealth appointments and patient records.
Screenshots
Product Updates (0)
No updates yet. Check back later for updates from the team.
Reviews (0)
No reviews yet. Be the first to rate this product!
Explore highly rated
You may also like
Mise
Get just the recipe without stories or ads
Comments (0)
No comments yet. Be the first to share your thoughts!